Search research articles
Contact Us
Filters
Showing results (691-700 of 832) with videos related to
Page
of 84
Sort By:
Nature Medicine
|
January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Practical Radiation Oncology
|
January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life
William C Jackson, Robert T Dess, Dale W Litzenberg, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Daniel M Geynisman, Philip H Abbosh, Eric Ross, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Page
of 84
Search research articles
Search
Showing results (691-700 of 832) with videos related to
Sort By:
Page
of 84
Nature Medicine
|
January 9, 2024
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L Levine, Marcelo C Pasquini, John E Connolly, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 19, 2021
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
N Nora Bennani, Aung M Tun, Kenneth R Carson, et al.
Practical Radiation Oncology
|
January 7, 2018
A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life
William C Jackson, Robert T Dess, Dale W Litzenberg, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Blood Advances
|
February 9, 2021
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Daniel M Geynisman, Philip H Abbosh, Eric Ross, et al.
Blood Advances
|
January 25, 2024
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Kurt S Bantilan, Alexandra N Smith, Matthew J Maurer, et al.
Haematologica
|
September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience
Giulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Blood
|
February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Page
of 84